SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-114529
Filing Date
2020-10-13
Accepted
2020-10-13 16:27:19
Documents
2
Period of Report
2020-10-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2033117d1_8k.htm 8-K 19748
2 EXHIBIT 99.1 tm2033117d1_ex99-1.htm EX-99.1 56888
  Complete submission text file 0001104659-20-114529.txt   77939
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 201236614
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences